DIGITAL BIOMANUFACTURING MARKET ANALYSIS
Digital biomanufacturing involves the digital technologies to improve the manufacturing process. It helps to enhanced the biological manufacturing by using computer aided design, verification and manufacture.
The global digital biomanufacturing market is estimated to be valued at US$ 17.92 billion in 2022 and is expected to exhibit a CAGR of 9.9% during the forecast period (2022-2030).
Figure 1. Global Digital Biomanufacturing Market, in Terms of Value (US$ Billion), By Region, 2022
To learn more about this report, request a free sample copy
Global Digital Biomanufacturing Market: Drivers
Emerging role of digital biomanufacturing is expected to drive the global market growth during the forecast period.
Digital biomanufacturing addresses unique aspects of biological activities and increase the data collection, monitoring, process control algorithms, automation, etc. Advances such as artificial intelligence (AI), automation, and robotics, are changing concepts of manufacturing in general from product development and factory operations to materials supply. Thus, emerging implementation of smart manufacturing in bio-based industries is likely boost the market growth in near future.
Digital Biomanufacturing Market Report Coverage
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2021 | Market Size in 2022: | US$ 17.92 Bn |
| Historical Data for: | 2017 to 2020 | Forecast Period: | 2022 to 2030 |
| Forecast Period 2022 to 2030 CAGR: | 9.9% | 2030 Value Projection: | US$ 38.14 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
3M, ABB, Cytiva, Siemens, immersciobio, Sanofi, BIOMÉRIEUX, Agilent Technologies, Inc., GE Healthcare, Culture Biosciences |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Figure 2. Global Digital Biomanufacturing Market Share (%), By Type, 2022
To learn more about this report, request a free sample copy
Expansion of digital biomanufacturing plants is expected to drive the global market growth over the forecast period
Key players are increasing their focus on expand the manufacturing process with innovative technologies to improve production process with research and development, paving the way for improved commercialization of important new medicines for patients . This in turn to drive the growth of market. For instance, in October 2019, Sanofi, a global biopharmaceutical company opened its first digitally enabled continuous manufacturing facility in Framingham, Massachusetts.
Global Digital Biomanufacturing Market – Impact of Coronavirus (COVID-19) Pandemic
The coronavirus (COVID-19) pandemic and consequent lockdown in various countries across the globe have impacted the financial status of businesses in all sectors. The private healthcare sector is one of the sectors, which has been majorly impacted by the pandemic. Thus, surge in adoption of digital technologies in biopharma sector during the pandemic is leads to boosting the demand for digital bioprocessing and thereby drive the growth of market.
Global Digital Biomanufacturing Market: Restraints
Lack of awareness regarding the technologically advanced services in emerging countries are the factors that are likely to hamper the growth of market.
Key Players
Major players operating in the global digital biomanufacturing market include 3M, ABB, Cytiva, Siemens, immersciobio, Sanofi, BIOMÉRIEUX, Agilent Technologies, Inc., GE Healthcare, Culture Biosciences
Frequently Asked Questions
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowWant to Buy a Report but have a Limited Budget?
We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount
Reliability and Reputation
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India :